Patents by Inventor Steven C. Pruitt

Steven C. Pruitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100216649
    Abstract: Provided are compositions and methods for identifying pairs of interacting proteins. The pair of plasmids is adapted for use in a modified two hybrid system wherein each plasmid comprises a recombinase recognition site. The method comprises the steps of providing cDNAs encoding test polypeptides, inserting the cDNAs into the first and second plasmids, recombining the first and second plasmids to obtain recombined plasmids, isolating and digesting the recombined plasmids to obtain cDNAs encoding pairs of interacting proteins, and determining the sequence of the digested fragments to determine pairs of interacting proteins.
    Type: Application
    Filed: January 25, 2008
    Publication date: August 26, 2010
    Inventors: Steven C. Pruitt, Alex R. Hastie, Lawrence M. Mielnicki
  • Patent number: 7323313
    Abstract: The present invention provides a method for identifying a plurality of pairs of interacting proteins and plasmids for use in the method. The pair of plasmids is adapted for use in a modified two hybrid system wherein wherein each plasmid comprises a recombinase recognition site. The method comprises the steps of providing cDNAs encoding test polypeptides, inserting the cDNAs into the first and second plasmids, recombining the first and second plasmids to obtain recombined plasmids, isolating and digesting the recombined plasmids, ligating the restriction fragments to a universal adapter to provide a pool of digested fragments flanked by a universal adapter, selecting and amplifying desired sequences, forming concatamers from the amplified sequences, and sequencing the concatamers to determine the nucleotide sequences encoding a plurality of pairs of interacting proteins.
    Type: Grant
    Filed: May 10, 2004
    Date of Patent: January 29, 2008
    Assignee: Health Research, Inc.
    Inventors: Steven C. Pruitt, Alexander Hastie, Lawrence Mielnicki
  • Patent number: 7083919
    Abstract: The present invention provides a method for screening of a large number of compounds for their ability to modulate the expression of genes. The method uses gene trap technology and comprises the steps of transfecting a population of cells with a gene-trap vector, sorting cells according to their level of fluorescence, distributing sorted cells into pools and expanding the pools to obtain a sufficient number of cells representing each trapped gene to permit distinction of the effect of a test compound over controls, exposing the cells to the test compounds and identifying compounds which alter the fluorescence distribution pattern of cells using FACS analysis.
    Type: Grant
    Filed: May 6, 2002
    Date of Patent: August 1, 2006
    Assignee: The Research Foundation of State University of New York
    Inventors: Steven C. Pruitt, David G. Hangauer, Carleton C. Stewart, Lawrence Mark Mielnicki
  • Publication number: 20030143578
    Abstract: The present invention provides a method for rapid identification of sites of insertion of DNA in to a cellular chromosome. The present invention also provides a gene trap vector. In one embodiment, the method of the present invention comprises the steps of stably transfecting a population of cells with a gene-trap vector, identifying cells with a trapped gene, distributing sorted cells into a matrix format, pooling cells from the matrix into discrete pools, producing cDNA sequence tags from the trapped genes in the pooled cells, making concatamers for each pool, cloning and sequencing the concatamers, defining the sequence tag of each well in the matrix.
    Type: Application
    Filed: August 26, 2002
    Publication date: July 31, 2003
    Inventors: Steven C. Pruitt, Lawrence M. Mielnicki
  • Publication number: 20020164636
    Abstract: The present invention provides a method for screening of a large number of compounds for their ability to modulate the expression of genes. The method uses gene trap technology and comprises the steps of transfecting a population of cells with a gene-trap vector, sorting cells according to their level of fluorescence, distributing sorted cells into pools and expanding the pools to obtain a sufficient number of cells representing each trapped gene to permit distinction of the effect of a test compound over controls, exposing the cells to the test compounds and identifying compounds which alter the fluorescence distribution pattern of cells using FACS analysis.
    Type: Application
    Filed: May 6, 2002
    Publication date: November 7, 2002
    Inventors: Steven C. Pruitt, David G. Hangauer, Carleton C. Stewart, Lawrence Mark Mielnicki
  • Patent number: 5238834
    Abstract: The present invention is directed to recombinant DNA vector molecules and uses therefor. More particularly, the present invention relates to the construction of recombinant vectors useful in the high frequency cloning of cDNA. The present invention also relates to vectors capable of directing the synthesis of single stranded cDNA and thereby permitting enrichment of specific sequences by hybridization/selection.
    Type: Grant
    Filed: May 22, 1992
    Date of Patent: August 24, 1993
    Assignee: Health Research, Inc.
    Inventor: Steven C. Pruitt